Biologist & Life Scientist jobs

Postdoctoral Fellow-MSH

Mount Sinai Health SystemUnited StatesPhD

Pay not listed

2 things to check before you apply.

On Mount Sinai Health System’s own careers site (Oracle Recruiting), checked open today.

  • To check: Posted by the employer 4 years agoLong-open jobs are sometimes already filled. Ask when they plan to hire.
  • To check: No pay range listedAsk for the pay range before you interview.
  • Checked: On the company's own careers siteOracle Recruiting board
  • Checked: Checked open todayOracle Recruiting board
  • Checked: No reposts foundOracle Recruiting board
  • Trust score 60 / 100 · Check details
See all 6 checksShow fewer
How we check

What you’ll do

  • Study transcription and post-transcriptional regulation in cancer.
  • Investigate therapeutic splicing inhibition through inhibition of arginine methylation.
  • Study the role of PRDM family enzymes in liver and colorectal cancer.

Summarised from the posting by AI and can be wrong. The full description is the source.

Requirements

Experience

  • Strong background in working with murine tumor models (preferred)
  • Background in cancer, RNA/chromatin biology, and familiarity with recent advances in these fields and NGS technologies (preferred)

Education

  • PhD in molecular biology or similar

Other requirements

  • Ability to work as part of a small team and report data clearly

Your match

Sign in and add your resume to see which of this job's requirements it shows.

Sign in to check your match

Saved to your account, encrypted. The AI that reads it doesn't keep it or train on it.

Benefits

Other
Competitive salary, Subsidized postdoctoral housing

Full job description

From Mount Sinai Health System’s careers site

Roles & Responsibilities:

Show full descriptionShow less

The Guccione Lab at the Icahn School of Medicine at Mount Sinai recently identified that inhibiting spliceosomal assembly through inhibition of arginine methylation provides an effective means of therapeutic splicing inhibition. Specifically, inhibiting either symmetric arginine methylation (mediated by the protein arginine methyltransferase 5 -PRMT5) or asymmetric dimethyl arginine methylation (mediated by type I PRMTs (PRMT1, 3, 4, and 6)) reduces splicing fidelity resulting in strong preferential killing of (i) splicing factor-mutant leukemias and (ii) MYC-overexpressing lymphomas over their wildtype counterparts. In addition the lab is investigating the role of members of the PRDM family of enzymes (e.g. PRDM9, PRDM10, PRDM15), in liver and colorectal cancer.

The successful applicant will be part of a highly productive research team studying transcription and post-transcriptional regulation in the context of cancer, with direct translational applicability. Applicants should be highly motivated and driven to study cancer epigenetics and RNA biology.

The successful candidate will be part of a thriving environment in the Department of Oncological Sciences within the Tisch Cancer Institute. The position offers competitive salary, subsidized postdoc-housing and exposure to a rich environment at Icahn School of Medicine at Mount Sinai and NYC.

Requirements:

  • PhD in molecular biology or similar
  • Strong background in working with murine tumor models is a plus.
  • Background in cancer, RNA/chromatin biology and familiarity with recent advances in these fields and NGS technologies is a plus.
  • Excellent communication skills. Must be able to work as part of a small team and report data clearly.
  • Proactive and problem-solving attitude is important

.

.

Something wrong with this job? Report it · This flag looks wrong

Similar jobs

See more like this